Annual prevalence of diabetic nephropathy in pediatric patients with diabetes for all cases stratified by age and sex and for probable cases only: U.S. MarketScan data, 2002–2003
Year | All cases | Probable cases only | |||||
---|---|---|---|---|---|---|---|
Age (years)* | Sex† | ||||||
<2 | 2 to < 6 | 6 to <12 | 12 to <18 | Male | Female | ||
2002 | n/a | 0.31 (0–1.72) | 0.20 (0.04–0.60) | 1.62 (1.23–2.08) | 0.95 (0.62–1.39) | 1.36 (0.96–1.87) | 0.83 (0.61–1.11) |
2003 | n/a | 0.18 (0–0.98) | 0.40 (0.19–0.74) | 2.21 (1.86–2.61) | 1.26 (0.96–1.63) | 1.94 (1.56–2.37) | 1.24 (1.03–1.49) |
2004 | n/a | 0.39 (0.08–1.13) | 0.68 (0.43–1.02) | 2.52 (2.19–2.88) | 1.66 (1.36–2.01) | 2.13 (1.79–2.52) | 1.46 (1.26–1.68) |
2005 | n/a | 0.55 (0.15–1.40) | 0.81 (0.55–1.16) | 3.14 (2.79–3.52) | 2.18 (1.85–2.56) | 2.57 (2.21–2.97) | 1.75 (1.53–1.98) |
2006 | n/a | 0.33 (0.04–1.19) | 0.89 (0.59–1.28) | 3.29 (2.91–3.70) | 2.27 (1.91–2.67) | 2.74 (2.35–3.19) | 1.97 (1.73–2.23) |
2007 | 2.44 (0.03–13.57) | 0.35 (0.07–1.02) | 0.89 (0.65–1.18) | 3.15 (2.86–3.46) | 2.24 (1.96–2.56) | 2.61 (2.30–2.95) | 1.91 (1.73–2.12) |
2008 | 5.26 (1.06–15.38) | 0.72 (0.29–1.49) | 1.21 (0.95–1.51) | 3.56 (3.28–3.86) | 2.62 (2.34–2.92) | 3.03 (2.73–3.36) | 2.19 (2.00–2.38) |
2009 | n/a | 0.79 (0.36–1.50) | 1.46 (1.20–1.76) | 3.70 (3.44–3.98) | 2.73 (2.46–3.02) | 3.25 (2.96–3.56) | 2.24 (2.07–2.42) |
2010 | 1.59 (0.02–8.83) | 1.08 (0.59–1.82) | 1.53 (1.28–1.82) | 3.63 (3.39–3.89) | 2.63 (2.39–2.89) | 3.34 (3.06–3.63) | 2.18 (2.02–2.35) |
2011 | n/a | 0.70 (0.34–1.29) | 1.51 (1.27–1.78) | 3.73 (3.49–3.97) | 2.78 (2.55–3.03) | 3.30 (3.04–3.57) | 2.17 (2.02–2.32) |
2012 | n/a | 0.22 (0.04–0.64) | 1.59 (1.34–1.87) | 3.94 (3.71–4.19) | 2.92 (2.68–3.17) | 3.55 (3.28–3.83) | 2.24 (2.09–2.40) |
2013 | n/a | 0.44 (0.14–1.03) | 1.29 (1.04–1.58) | 4.30 (4.03–4.58) | 3.04 (2.77–3.32) | 3.86 (3.55–4.19) | 2.32 (2.16–2.50) |